Anzeige
❌
Mehr »
Dienstag, 06.10.2026 - Börsentäglich über 12.000 News
Volltreffer: 24,3 Meter mit 10,14 g/t Gold - ist dieser 18-Mio.-CAD-Explorer viel zu billig?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
AM

WKN: A14WL9 | ISIN: FR0011051598 | Ticker-Symbol: A1H
Stuttgart
06.10.26 | 10:03
0,325 Euro
-0,91 % -0,003
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
AMOEBA Chart 1 Jahr
5-Tage-Chart
AMOEBA 5-Tage-Chart
RealtimeGeldBriefZeit
0,3150,34510:25

Aktuelle News zur AMOEBA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06:02XFRA CAPITAL ADJUSTMENT INFORMATION - 06.10.202646Das Instrument 2QO US74736K1016 QORVO INC.DL -,0001 EQUITY wird ex Kapitalmassnahme gehandelt am 06.10.2026 The instrument 2QO US74736K1016 QORVO INC.DL -,0001 EQUITY is traded ex capital adjustment...
► Artikel lesen
FrAMOEBA: Amoéba aims to involve its shareholders in its latest fundraising round, ahead of the monetisation of its cosmetics platform, to finance its commercial launch4.182Press release This press release must not be circulated, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
25.09.AMOEBA: Amoéba announces the success of the first phase of its fundraising campaign aimed at achieving financial self-sufficiency590Press Release This press release may not be released, published, or distributed, directly or indirectly, in or into the United States of America, Canada, Australia, or Japan. This press...
► Artikel lesen
24.09.AMOEBA: Amoéba launches a two-phase capital increase expected to be its final market financing before achieving financial self-sufficiency464Press Release This press release may not be released, published, or distributed, directly or indirectly, in or into the United States of America, Canada, Australia, or Japan. This press...
► Artikel lesen
24.09.AMOEBA: Amoéba becomes an industrial and commercial company in biocontrol and initiates a process to monetize its cosmetics asset656Amoéba completed its transition into an industrial and commercial company in biocontrol in H1 2026, with the delivery of its first biocontrol orders; Provisional H1 2026 financial...
► Artikel lesen
10.09.Amoeba: Syngenta und Amoéba schließen exklusiven europäischen Vertriebsvertrag, um Getreideerzeugern ein wegweisendes Biofungizid bereitzustellen804Basel, Schweiz, und Chassieu, Frankreich, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Die exklusive Vereinbarung umfasst den Getreidemarkt in der Europäischen Union, im Vereinigten Königreich, in der Ukraine...
► Artikel lesen
08.09.AMOEBA: Syngenta and Amoéba Seal Exclusive European Distribution Deal, Aiming to Bring a Breakthrough Biofungicide to Cereal Growers879The exclusive agreement will span the cereals market across the European Union, the United Kingdom, Ukraine and Switzerland, with first market launches from 2028/29; This new-generation biocontrol...
► Artikel lesen
AMOEBA Aktie jetzt für 0€ handeln
23.07.AMOEBA: Amoéba and Koppert extend their distribution agreement for AXPERA technology and reaffirm their shared ambitions in the field of innovative biofungicides825Chassieu (France), 23 July 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, and its partner Koppert, world...
► Artikel lesen
30.06.AMOEBA: Amoéba has received marketing authorization in France for its biofungicide AXPERA807Chassieu (France), 30 June 2026 - 07:30 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
08.06.AMOEBA: Amoéba obtains in Italy a 120 day emergency authorization for the use of its biofungicide AXPERA against basil downy mildew782Chassieu (France), 8 June 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained...
► Artikel lesen
06.05.AMOEBA: Two new exceptional trial permits in the Netherlands in 2026 for Amoéba's biocontrol solution1.252Amoéba and Koppert have each been granted special authorization to use AXPERA technology on a wide range of crops These exemptions include food crops for consumption. Chassieu (France), 6...
► Artikel lesen
28.04.AMOEBA: Amoéba has obtained a new emergency authorization for the use of the AXPERA biocontrol solution to protect French vineyards727Chassieu (France), 28 April 2026 - 6:00 p.m. - Amoéba (FR0011051598 - ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has received...
► Artikel lesen
13.04.AMOEBA: Amoéba and Koppert highlight the potential of AXPERA technology in Brazil for strategic crops659Chassieu (France), 13 April 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
26.03.AMOEBA: Amoéba announces the success of its capital increase and raises EUR 6.67 million1.501Chassieu (France), 26 March 2026 - 8:00 a.m. - Amoéba (FR0011051598 - ALMIB ), an industrial greentech specialized in the development of natural microbiological solutions based on the patented...
► Artikel lesen
25.03.AMOEBA: Amoéba strengthens its financial visibility to support its industrial and commercial expansion1.687Press release This press release must not be released, published or distributed, directly or indirectly, within or to the United States of America, Canada, Australia or Japan. This press...
► Artikel lesen
19.03.Amoeba - Preparing for commercialisation in 2026903Amoéba's FY25 was marked by regulatory and pre-commercial progress across biocontrol and cosmetics, alongside higher industrial deployment spend ahead of a planned move into commercialisation in 2026....
► Artikel lesen
19.03.AMOEBA: Amoéba: Ordinary and Extraordinary General Meeting of 3 April 2026774Chassieu (France), 19 March 2026 - 8:45 am - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of...
► Artikel lesen
18.03.AMOEBA: Amoéba announces the publication of its Universal Registration Document 2025618Chassieu (France), 18 March 2026 - 6 p.m. - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialized in the development of natural microbiological solutions based on the patented use...
► Artikel lesen
11.03.AMOEBA: Amoéba receives its first order from Koppert and confirms its transformation into a commercial company795Press release Chassieu (France), 11 March 2026 - 6:00 pm - Amoéba (FR0011051598 - ALMIB), industrial greentech specialised in the development of natural microbiological solutions based...
► Artikel lesen
23.02.AMOEBA: Amoéba: final phase for marketing authorisation of AXPERA736The ANSES evaluation process for the application submitted in March 2025 is currently in its final stage. At the same time, French and Italian agricultural sectors have begun procedures to obtain...
► Artikel lesen
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1